Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk
- PMID: 17080985
Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk
Comment on
-
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.N Engl J Med. 2006 Jul 13;355(2):125-37. doi: 10.1056/NEJMoa062462. N Engl J Med. 2006. PMID: 16837676 Clinical Trial.